Human monoclonal antibodies in single chain fragment variable format with potent neutralization activity against influenza virus H5N1.
about
Monoclonal antibody-based therapies for microbial diseasesH5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer modelPseudotype-based neutralization assays for influenza: a systematic analysis.Combination of specific single chain antibody variable fragment and siRNA has a synergistic inhibitory effect on the propagation of avian influenza virus H5N1 in chicken cells.
P2860
Human monoclonal antibodies in single chain fragment variable format with potent neutralization activity against influenza virus H5N1.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Human monoclonal antibodies in ...... against influenza virus H5N1.
@ast
Human monoclonal antibodies in ...... against influenza virus H5N1.
@en
type
label
Human monoclonal antibodies in ...... against influenza virus H5N1.
@ast
Human monoclonal antibodies in ...... against influenza virus H5N1.
@en
prefLabel
Human monoclonal antibodies in ...... against influenza virus H5N1.
@ast
Human monoclonal antibodies in ...... against influenza virus H5N1.
@en
P2093
P50
P1433
P1476
Human monoclonal antibodies in ...... against influenza virus H5N1.
@en
P2093
Barbara Capecchi
Eliana Pittiglio
Isabella Alberini
Isabella Donatelli
Laura Campitelli
Maurizio Cianfriglia
Silvia Zamboni
Valentina Imperiale
P304
P356
10.1016/J.ANTIVIRAL.2009.05.005
P577
2009-05-27T00:00:00Z